“…In addition, we provided evidence for the existence of a complex hormonal balance, between glucocorticoids and androgens, in the control of RACK1 expression and immune cells activation, suggesting that RACK1 can be targeted by EDC ( Buoso et al, 2017a ; Buoso et al, 2017b ; Racchi et al, 2017 ; Buoso et al, 2020b ; Buoso et al, 2020c ). We demonstrated that glucocorticoid hormones decrease RACK1 expression while androgens and estrogens increase it ( Buoso et al, 2017a ; Buoso et al, 2017b ; Racchi et al, 2017 ; Buoso et al, 2020b ; Buoso et al, 2020c ). In this regard, some EDCs have been shown to have effects on RACK1, including the antiandrogens p,p’- dichlorodiphenyltrichloroethane ( p,p’- DDT) and p,p’ -dichlorodiphenyldichloroethylene ( p,p’ -DDE) ( Buoso et al, 2017a ), and the estrogen-active compounds diethylstilbestrol (DES) and zearalenone (ZEA) ( Buoso et al, 2020b ).…”